BAILEY, SIMON S,.貝利,BURKE, BENJAMIN, JOSEPH BJ,.伯克,COLLINS, MICHAEL, RAYMOND MR,.柯林斯,CUI, JINGRONG, JEAN JJ,.崔,DEAL, JUDITH, GAIL JG,.迪爾,HOFFMAN, ROBERT, LOUIS RL,.霍夫曼,HUANG, QINHUA Q,.黃,JOHNSON, TED,
申请号：
HK14112733.1
公开号：
HK1199247B
申请日:
2014.12.19
申请国别(地区):
HK
年份:
2017
代理人:
摘要：
The invention relates to compounds of formula (&Phi) as further defined herein and to the pharmaceutically acceptable salts thereof, to pharmaceutical compositions comprising such compounds and salts, and to the uses thereof. The compounds and salts of the present invention inhibit anaplastic lymphoma kinase (ALK) and/or EML4-ALK and are useful for treating or ameliorating abnormal cell proliferative disorders, such as cancer.
